Past EBSA courses

Instructors Fred Wassenaar & Patrick Rüdelsheim

Gene drives allow for a trait to be transmitted to subsequent generations in a ratio that deviates from the laws of Mendelian inheritance. Active in sexually-reproducing species, they are powerful tools to “drive” ... read all info and register here

RE-RUN UPON POPULAR DEMAND (confirmation as soon as we have 25 participants)

The ISO 35001 standard on “Biorisk management for laboratories and other related organisations - is the first internationally recognized management standard to specifically address hazards associated with laboratories where biological materials are handled at all containment levels. 

Course completely in French
Cours entièrement en français

Ce cours est une introduction au sujet. Il décrit les approches les plus utilisées, en mettant l’accent sur les critères important à évaluer pour le choix d’une approche et la vérification de son efficacité.

RE-RUN UPON POPULAR DEMAND (confirmation as soon as we have 25 participants)

In this webinar these and other questions will be addressed by using the risk based approach of the new WHO biosafety manual. 

The ISO 35001 standard on “Biorisk management for laboratories and other related organisations - is the first internationally recognized management standard to specifically address hazards associated with laboratories where biological materials are handled at all containment levels. 

The course in French is supported by the German Biosecurity Program (sold out)

La gestion des risques biologiques dans divers environnements dans lesquels des matières biologiques dangereuses sont utilisées, que ce soit dans la recherche, le diagnostic, les installations de production ou les unités animales, est de la plus haute importance. Les professionnels de la biosécurité jouent très souvent l'interface entre différents acteurs tels que les scientifiques, l'ingénierie, le personnel d'entretien ou de nettoyage.

The course in French is supported by the German Biosecurity Program (sold out)

Though the idea for gene therapy was put forward in 1972, it was not until 2003 in China and 10 years later in US, that DNA drug actually appeared on the market. Since then, at least nine gene therapies have been approved for a few cancer types, genetic disorders and viral infections and a great number of research projects and clinical trials are underway in many countries.